These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

306 related items for PubMed ID: 10440874

  • 1. Characterization of nerve growth factor precursor protein expression by human prostate stromal cells: a role in selective neurotrophin stimulation of prostate epithelial cell growth.
    Delsite R, Djakiew D.
    Prostate; 1999 Sep 15; 41(1):39-48. PubMed ID: 10440874
    [Abstract] [Full Text] [Related]

  • 2. Molecular characterization of neurotrophin expression and the corresponding tropomyosin receptor kinases (trks) in epithelial and stromal cells of the human prostate.
    Dalal R, Djakiew D.
    Mol Cell Endocrinol; 1997 Oct 31; 134(1):15-22. PubMed ID: 9406845
    [Abstract] [Full Text] [Related]

  • 3. Characterization of nerve growth factor precursor protein expression in rat round spermatids and the trophic effects of nerve growth factor in the maintenance of Sertoli cell viability.
    Chen Y, Dicou E, Djakiew D.
    Mol Cell Endocrinol; 1997 Mar 28; 127(2):129-36. PubMed ID: 9099908
    [Abstract] [Full Text] [Related]

  • 4. Expression of a Trk high affinity nerve growth factor receptor in the human prostate.
    Pflug BR, Dionne C, Kaplan DR, Lynch J, Djakiew D.
    Endocrinology; 1995 Jan 28; 136(1):262-8. PubMed ID: 7828539
    [Abstract] [Full Text] [Related]

  • 5. Regulation of growth by a nerve growth factor-like protein which modulates paracrine interactions between a neoplastic epithelial cell line and stromal cells of the human prostate.
    Djakiew D, Delsite R, Pflug B, Wrathall J, Lynch JH, Onoda M.
    Cancer Res; 1991 Jun 15; 51(12):3304-10. PubMed ID: 1710170
    [Abstract] [Full Text] [Related]

  • 6. Rational basis for Trk inhibition therapy for prostate cancer.
    Weeraratna AT, Arnold JT, George DJ, DeMarzo A, Isaacs JT.
    Prostate; 2000 Oct 01; 45(2):140-8. PubMed ID: 11027413
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Anti-proliferative effect of the kinase inhibitor K252a on human prostatic carcinoma cell lines.
    Delsite R, Djakiew D.
    J Androl; 1996 Oct 01; 17(5):481-90. PubMed ID: 8957691
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Mast cells differentially express and release active high molecular weight neurotrophins.
    Skaper SD, Pollock M, Facci L.
    Brain Res Mol Brain Res; 2001 Dec 30; 97(2):177-85. PubMed ID: 11750074
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Neurotrophin receptor p75(NTR) suppresses growth and nerve growth factor-mediated metastasis of human prostate cancer cells.
    Krygier S, Djakiew D.
    Int J Cancer; 2002 Mar 01; 98(1):1-7. PubMed ID: 11857376
    [Abstract] [Full Text] [Related]

  • 15. Reduced expression of the low affinity nerve growth factor receptor in benign and malignant human prostate tissue and loss of expression in four human metastatic prostate tumor cell lines.
    Pflug BR, Onoda M, Lynch JH, Djakiew D.
    Cancer Res; 1992 Oct 01; 52(19):5403-6. PubMed ID: 1382843
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. NGF induces apoptosis in a human neuroblastoma cell line expressing the neurotrophin receptor p75NTR.
    Kuner P, Hertel C.
    J Neurosci Res; 1998 Nov 15; 54(4):465-74. PubMed ID: 9822157
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.